Company

RyboDyn Inc.

Biotechnology Research 10935 Alexandria Way 13 employees

Employees: 13
Contacts: 4
Emails: 4
Phones: 3

www.rybodyn.com LinkedIn Crunchbase

RyboDyn Inc. Overview

Headquarters: 10935 Alexandria Way
Website: www.rybodyn.com
Industry: Biotechnology Research
Employees: 13
Founded: 2022
Funding: 4.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

📈 Accelerated pipeline — building on data co-generated with Moffitt Cancer Center that confirms conserved

About RyboDyn Inc.

RyboDyn, Inc. is targeting the dark proteome to make new immunotherapies. We are unlocking and validating previously undiscovered, disease-specific targets that will impact the treatment of cancer and autoimmune diseases by driving a new wave of targeted therapeutics. Our "targets-to-assets" therapeutics development program is supported by a scalable, in-house platform for lead discovery and optimization. We aim to deliver first-in-class assets that recognize these targets for treating solid tumors and diseases lacking effective treatment options.

RyboDyn Inc. Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 3; 75.0% coverage

RyboDyn Inc. Org Chart

Sample employees and titles

Name	Title	Location	Contact
Imad Ajjawi, Phd, Mba	CEO and Co-founder, Rybodyn Inc.	San Diego, California, United States	Email Phone
Jay Patil	Swell Partners // Venture Capital	New York, United States	Email Phone
Marco Blanchette	Health Science Executive - Genomic	Scotts Valley, California, United States	Email Phone
Jessica Weir	Senior Associate Scientist at Rybodyn	San Diego, California, United States	Email